Symrise Investors Eye Dividend Hike and First Quarter Results

Symrise proposes 16th straight dividend increase to €1.25. Q1 results due as US DOJ ends antitrust probe, removing uncertainty. Shares up 8.4% YTD.

Spring brings a packed schedule for shareholders of the flavors and fragrances producer Symrise. The imminent annual general meeting is set to approve another dividend increase, while the company's first-quarter report will provide a crucial early check on its annual performance. This comes as a significant legal overhang from the United States has been recently cleared.

Dividend Proposal and Upcoming Milestones

Following robust 2025 results that saw the operating margin rise to 21.9%, the focus now shifts to two key dates:

• April 29, 2026: Publication of Q1 financial results.
• May 6, 2026: Ordinary Annual General Meeting in Holzminden.

At the shareholder meeting, the supervisory board will propose a distribution of €1.25 per share. If approved by investors, this will mark the sixteenth consecutive annual dividend increase.

U.S. Legal Investigation Concluded

The company has resolved a major burden from its recent past. The U.S. Department of Justice has discontinued its investigation into allegations of anti-competitive agreements after finding no evidence of unlawful conduct. While the European Commission continues its own probe into the same matter, the UK competition authority closed its case last year. This development removes a notable source of uncertainty.

On the stock market, Symrise shares have gained 8.42% since the start of the year, recently trading at €74.16.

Trade Policy and Growth Targets

For the full 2026 fiscal year, management is targeting organic sales growth of between two and four percent. However, U.S. trade policy remains a substantial uncertainty. Given the company's significant export volumes to the United States, unpredictable tariff risks present a potential obstacle to a more optimistic outlook.

The upcoming quarterly report at the end of April will deliver the first concrete data point on whether the volume expansion forecast by management for the current business year is taking hold. Market analysts are largely confident; UBS recently reaffirmed its price target of €92 for the equity.